Department of Ophthalmology
University of Colorado Denver
Anschutz Medical Campus
1675 Aurora Court, Mail Stop F-731
Aurora, CO 80045
Appointments: (720) 848-2020
Curriculum Vitae
Dr. Mandava is a specialist in the medical and surgical managment of retinal diseases such as macular degeneration, diabetic retinopathy and retinal detachment. The retinal service participates in several national clinical trials including treatments for macular degeneration, diabetic retinopathy and retinal detachment. The University of Colorado has the most up-to-date specialized equipment for retinal surgery. His research interests include antiangiogenesis in macular degeneration, diabetic retinopathy, complex retinal detachment and ocular trauma.
EYE CONDITIONS:
Macular degeneration, diabetic retinopathy and retinal detachment.
ENROLLING STUDIES:
Anti-PDGF Combination Injection for New Wet Macular Degeneration
Ocriplasmin for Injection for Wet Macular Degeneration and Vitreomacular Adhesion
ACTIVE STUDIES:
HARBOR - high dose ranibizumab for wet-AMD
RISE - ranibizumab for DME
EDUCATION:
- Medical School: Albany Medical College, Albany New York.
- Residency: (Ophthalmology) Manhattan Eye, Ear and Throat Hospital, New York.
- Fellowship: (Vitreoretinal Diseases) Manhattan Eye, Ear and Throat Hospital and Columbia University Hospital, New York.
AWARDS:
2004-2007 Top Ophthalmologists in America.
2007 American Academy of Ophthalmology Honor Award.
2008 5280 Top Doctors Listing.
2009 5280 Top Doctors Listing .
PUBLICATIONS: Naresh Mandava, MD